# Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment

> **NCT00574249** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 730 (actual)

## Conditions studied

- Chronic Plaque Psoriasis

## Interventions

- **BIOLOGICAL:** adalimumab
- **DRUG:** Calcipotriol/Betamethasone Ointment
- **DRUG:** placebo (vehicle ointment)

## Key facts

- **NCT ID:** NCT00574249
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 730 (ACTUAL)
- **Last updated:** 2011-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574249, "Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00574249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*